Abemaciclib-Faslodex Combo Increases Progression-free Survival in Advanced Breast Cancer
News
Adding the CDK4/6 inhibitor abemaciclib to Faslodex (fulvestrant) is a promising way to treat patients with an advanced breast cancer who experienced a relapse or had their disease progress after ... Read more